The multibiomarker test will provide the clinical research community with a noninvasive tool to identify and monitor patients with NASH and significant fibrosis.
Read MoreThe acquisition enhances Qiagen’s market leadership with access to N-of-One’s MarkerMine database and real-world evidence that provides insights for targeted therapy options.
Read More
The research panels can be performed using Qiagen’s GeneReader NGS system and other platforms, providing deep analysis of disease-related genomic mutations.
Read MoreThe first such device to receive FDA clearance, Inova’s fecal extraction device provides significant workflow improvement to the laboratory.
Read More
The partners’ study combines Neon’s personal neoantigen vaccine and Signatera’s circulating tumor DNA assay in a trial for metastatic non-small cell lung cancer.
Read More